Twist Bioscience (TWST) Net Margin (2017 - 2026)

Twist Bioscience (TWST) has reported Net Margin for 10 consecutive years, with 29.61% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Margin fell 5083.0% year-over-year to 29.61% in Q2 2026; TTM through Jun 2026 was 31.66%, a 814.0% decrease from a year earlier, with the FY2025 full-year figure at 20.63%, up 4608.0% from the prior year.
• Net Margin was 29.61% for Q2 2026 at Twist Bioscience, up from 39.76% in the prior quarter.
• Over five years, Net Margin peaked at 21.22% in Q2 2025 and troughed at 126.06% in Q1 2022.
• A 5-year average of 61.51% and a median of 60.28% in 2023 frame the typical range for Net Margin.
• Across the five-year window, Net Margin surged 12627 bps in 2025 and tumbled 5083 bps in 2026, its largest moves.
• Over 5 years, Net Margin stood at 77.1% in 2022, then increased by 22 bps to 60.15% in 2023, then soared by 41 bps to 35.62% in 2024, then gained by 17 bps to 29.46% in 2025, then declined by 0 bps to 29.61% in 2026.
• The last three Net Margin figures came in at 29.61% (Q2 2026), 39.76% (Q1 2026), and 29.46% (Q4 2025), per Business Quant data.